In vivo evaluation of alginate microspheres of carvedilol for nasal delivery

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 1, 2012, Pages 249-255

  Patil, Sanjay B ^a   Kaul, Ankur ^b   Babbar, Anil ^b   Mathur, Rashi ^b   Mishra, Anil ^b   Sawant, Krutika K ^c  

^a Shri Neminath Jain Brahmacharyashram's Shriman Sureshdada Jain College of Pharmacy   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c M S UNIVERSITY OF BARODA   (India)

Author keywords

alginate microspheres; carvedilol; nasal administration; pharmacokinetics

Indexed keywords

AREA UNDER THE CURVES; CARVEDILOL; FREE FLOWING POWDERS; IN-VIVO; INTRAVENOUS ADMINISTRATION; NASAL ADMINISTRATION; NASAL CAVITY; NASAL DELIVERY; NEW ZEALAND WHITE RABBIT; NONINVASIVE TECHNIQUE; PHARMACOKINETIC ANALYSIS; RADIOLABELING; RELATIVE BIOAVAILABILITY; SMOOTH SURFACE; SPHERICAL SHAPE; TECHNETIUM-99M;

ALGINATE; BIOCHEMISTRY; EMULSIFICATION; NUCLEAR MEDICINE; PHARMACOKINETICS; RADIOACTIVITY; SCINTILLATION COUNTERS; SUGARS; TECHNETIUM;

MICROSPHERES;

ALGINIC ACID; CARVEDILOL; MICROSPHERE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; EMULSION; GAMMA SCINTIGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; RABBIT; RADIOACTIVITY; SCINTILLATION;

ADMINISTRATION, INTRANASAL; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ALGINATES; ANIMALS; BIOLOGICAL AVAILABILITY; CARBAZOLES; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GLUCURONIC ACID; HEXURONIC ACIDS; ISOTOPE LABELING; LACTOSE; MICROSPHERES; NASAL CAVITY; PROPANOLAMINES; RABBITS; RADIONUCLIDE IMAGING; SHEEP; TECHNETIUM;

EID: 82955212988     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31947     Document Type: Article

References (30)

1. Behl CR, Pimplaskar HK, Sileno AP, deMeireles J, Romeo VD,. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 1998; 29: 89-116. (Pubitemid 28044088)
2. Mygind N, Dahl R,. Anatomy, physiology and function of the nasal cavity in health and disease. Adv Drug Deliv Rev 1998; 29: 3-12. (Pubitemid 28044084)
3. Illum L,. Nasal drug delivery-possibilities, problems and solutions. J Control Release 2003; 87: 187-198. (Pubitemid 36255456)
4. Ugwoke MI, Verbeke N, Kinget R,. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001; 53: 3-21. (Pubitemid 32140298)
5. Â) in allergic rhinitis treatment. Biomaterials 2004; 25: 159-170. (Pubitemid 37324409)
6. Illum L, Jorgensen H, Bisgaard H, Krogsgaard O, Rossing N,. Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm 1987; 39: 189-199. (Pubitemid 17147761)
7. Sachetti C, Artusi M, Santi P, Colombo P,. Caffeine microparticles for nasal administration obtained by spray drying. Int J Pharm 2002; 242: 335-339.
8. Mao S, Chen J, Wei Z, Liu H, Bi D,. Intranasal administration of melatonin starch microspheres. Int J Pharm 2003; 272: 37-43.
9. Gavini E, Rassa G, Vanna S, Massimo C, Giunchedi P,. Mucoadhesive microspheres for nasal administration of an antiemetic drug metaclopramide: In vitro/ex-vivo studies. J Pharm Pharmacol 2004; 57: 287-294. (Pubitemid 40314426)
10. Martinac A, Filipovic-Grcic J, Voinovich D, Perissutti B, Franceschinis E,. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 2005; 291: 69-77. (Pubitemid 40221998)
11. Patil SB, Murthy RSR,. Preparation and in vitro evaluation of mucoadhesive chitosan microspheres of amlodipine besylate for nasal administration. Indian J Pharm Sci 2006; 8: 64-67.
12. Gavini E, Hegge AB, Rassa G, Vanna S, Testa C, Pirisino G, Karlsen J, Giunchedi P,. Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies, Int J Pharm 2006; 307: 9-15. (Pubitemid 41773246)
13. Patil SB, Sawant KK,. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery. J Microencapsul 2009; 26: 432-443.
14. Patil SB, Babbar AK, Mathur R, Mishra AK, Sawant KK,. Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Target 2010; 18: 321-331.
15. Patil SB, Sawant KK,. Chitosan microspheres as a delivery system for nasal insufflation. Colloids Surf B Biointerfaces 2011; 84: 384-389.
16. Illum L,. Bioadhesive formulations for nasal peptide delivery. In:, Mathiowitz E, Lehr CM, Chickering D, editors. Bioadhesion in Drug Delivery-Issues in Fundamentals, Novel Approaches and Development. New York: Marcel Decker; 1998. pp 507-539.
17. Bernkop-Schnurch A,. Mucoadhesive polymers. In:, Dumitriu S, editor. Polymer Biomaterial. New York: Marcel Decker; 2002. pp 147-165.
18. Stokke BT, Draget KI, Smidsrod O, Yuguchi Y, Urakawa H, Kajiwara K,. Small angle X-ray scattering and rheological characterization of alginate gels. 1. Calcium alginate gels. Macromolecules 2000; 33: 1853-1863. (Pubitemid 30589094)
19. Emmerichs N, Wingender J, Flemming HC, Mayer C,. Interaction between alginates and manganese cations: Identification of preferred cation binding sites. Int J Biol Macromol 2004; 34: 73-79. (Pubitemid 38721188)
20. Serp D, Cantana E, Heinzen C, Stockar UV, Marison IW,. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol Bioeng 2000; 70: 41-53.
21. Chan LW, Jin Y, Heng PWS,. Cross-linking mechanisms of calcium and zinc in production of alginate microspheres. Int J Pharm 2002; 242: 255-258.
22. Tafaghodi M, Tabassi SAS, Jaafari MR, Zakavi SR, Momen-Nejad M,. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm 2004; 280: 125-135. (Pubitemid 38950910)
23. Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RSR,. Thermoreversible- mucoadhesive gel for nasal delivery of sumatriptan. AAPS Pharm Sci Technol 2006; 7:Article 67.
24. 99mTc-labeled liposome encapsulated cyclosporine. J Drug Target 2003; 11: 187-196. (Pubitemid 37236332)
25. Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RS,. Celecoxib incorporated chitosan microspheres: In vitro and in vivo evaluation. J Drug Target 2004; 12: 549-557. (Pubitemid 40100702)
26. Boling LR,. Regeneration of nasal mucosa. Arch Otolaryngol 1935; 22: 689-742.
27. Illum L, Fisher AN, Jabbal-Gill I, Davis SS,. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm 2001; 222: 109-119. (Pubitemid 32525792)
28. Pereswetoff-Morath, L,. Microspheres as nasal drug delivery systems. Adv Drug Deliv Rev 1998; 29: 185-194. (Pubitemid 28044094)
29. Ingels K, Van Hoom, V, Obrie E, Osmanagaoglu K,. A modified technetium-99m isotope test to measure nasal mucocillary transport: Comparison with the saccharine-dye test. Eur Arch Otorhinolaryngol 1995; 252: 340-343.
30. Schipper NGM, Verhoef JC, Merkus FWHM,. The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm Res 1991; 8: 807-814.